Instrumento Inactivo

Acciones Transition Therapeutics Inc

Acciones

Duración

Período

Estilo

Transition Therapeutics : Announces Special Shareholder Meeting Voting Results Including Shareholder Approval of the Plan of Arrangement with OPKO Health, Inc.	26/08/16
Transition Therapeutics : Receives Notification From NASDAQ	03/06/16
Transition Therapeutics : Announces Third Quarter Fiscal 2016 Financial Results	11/05/16
Transition Therapeutics to Hold Conference Call on Third Quarter Fiscal 2016 Financial Results on Wednesday, May 11th, at 4:30 P.M. EST	09/05/16
Transition Therapeutics : Provides Update on Type 2 Diabetes Drug Candidate TT401	18/04/16

Directores	Puesto	Edad	Desde
Antonio F. Cruz CEO	Chief Executive Officer	71	06/07/98

Administradores	Puesto	Edad	Desde
Antonio F. Cruz CEO	Chief Executive Officer	71	06/07/98

Sector

	Varia. 1 de ene.	Capi.
CSL LIMITED	-4,66 %	86,13 mil M
SAMSUNG BIOLOGICS CO.,LTD.	+1,32 %	39,82 mil M
BIOGEN INC.	-19,27 %	30,42 mil M
UCB	+57,86 %	25,23 mil M
INCYTE CORPORATION	-17,69 %	11,6 mil M
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.	-43,00 %	11,51 mil M
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.	-9,14 %	11,95 mil M
SWEDISH ORPHAN BIOVITRUM AB	+5,24 %	8710,47 M
INNOVENT BIOLOGICS, INC.	-8,42 %	8115,21 M